Crescent Capital BDC (NASDAQ:CCAP) Releases Earnings Results, Beats Expectations By $0.01 EPS

Crescent Capital BDC (NASDAQ:CCAP) released its quarterly earnings results on Monday. The company reported $0.59 EPS for the quarter, topping analysts’ consensus estimates of $0.58 by $0.01, Yahoo Finance reports. Crescent Capital BDC had a net margin of 53.32% and a return on equity of 11.99%. The business had revenue of $48.95 million for the quarter, compared to analyst estimates of $48.05 million. During the same period last year, the firm earned $0.56 earnings per share.

Crescent Capital BDC Stock Down 0.7 %

Crescent Capital BDC stock traded down $0.13 during mid-day trading on Tuesday, reaching $17.85. The stock had a trading volume of 22,570 shares, compared to its average volume of 140,531. The stock’s 50-day simple moving average is $18.76 and its 200-day simple moving average is $17.72. Crescent Capital BDC has a fifty-two week low of $15.03 and a fifty-two week high of $19.63. The company has a debt-to-equity ratio of 1.11, a quick ratio of 1.36 and a current ratio of 1.36. The firm has a market capitalization of $661.56 million, a PE ratio of 6.40 and a beta of 0.81.

Crescent Capital BDC Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, July 15th. Investors of record on Friday, June 28th were paid a dividend of $0.42 per share. This is an increase from Crescent Capital BDC’s previous quarterly dividend of $0.41. This represents a $1.68 dividend on an annualized basis and a yield of 9.41%. The ex-dividend date was Friday, June 28th. Crescent Capital BDC’s dividend payout ratio is 59.79%.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on CCAP shares. Keefe, Bruyette & Woods lifted their price target on shares of Crescent Capital BDC from $18.50 to $19.00 and gave the company an “outperform” rating in a report on Thursday, May 23rd. Wells Fargo & Company lifted their price objective on Crescent Capital BDC from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research note on Friday, July 26th. Finally, Raymond James increased their target price on shares of Crescent Capital BDC from $18.00 to $19.00 and gave the company an “outperform” rating in a research report on Friday, May 10th.

About Crescent Capital BDC

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.